Rights and permissions
About this article
Cite this article
Epratuzumab plus rituximab make the cut with CHOP therapy for DLBCL. Inpharma Wkly. 1572, 6 (2007). https://doi.org/10.2165/00128413-200715720-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715720-00015